Its made out of 3 non-essential amino acids, namely cysteine, glycine, and glutamic acid
Peripheral effects Via the AMY2 and AMY3 receptors Cagrilintide acts peripherally: Slowing of gastric emptying , stronger than with GLP-1 Suppression of postprandial glucagon , helps control postprandial glycemic spikes Modulation of bone remodeling (via AMY3), a neutral effect, but clinically monitored Synergy with GLP-1 (the mechanistic basis of CagriSema) The main innovation is the complementarity with the GLP-1 pathway : GLP-1 suppresses appetite via the arcuate nucleus of the hypothalamus (POMC neurons, AgRP/NPY inhibition) Amylin suppresses appetite via the area postrema (CGRP-like neurons) Two independent centers, two independent mechanisms
In other words, the schedule is a sensible default that a clinician can adjust, not a fixed rule you should try to bend on your own
doi:10.1038/s41598-019-44631-3 Maharaj D, Srinivasan G, Makepeace S, Hickey CJ, Gouvea J
Thigh injections produced roughly half the rate of nausea compared to abdominal injections
Subcutaneous sites include the abdomen and outer upper arms
